Developing controlled and economical rAAV therapies requires the co-development of robust and reliable characterization tools to control and optimize a sample’s critical quality attributes (CQAs).

In this webinar, we will demonstrate how you can use OMNISEC for the extended characterization of different AAV serotypes. You’ll learn how this technique allows you to evaluate and compare viral titer, capsid empty/full ratios, impurity and aggregate profiling - all of which impact the final product’s CQAs.

Importantly, we will show why OMNISEC allows you make measurements without the use of dedicated and costly reference standards that frequently limit the application of other methodologies.

Register now to see how we are pushing the limits of rAAV analysis with OMNISEC!

Summary

Measurement type:
Molecular size
Date:
May 05 2021 - May 05 2021
Time:
10:30 - 11:30
Eastern Time [US & Canada]
Event type:
Webinar - Live
Language:
English
Products:
OMNISEC system
Zetasizer Ultra (Red)
Zetasizer Advance Range
Technology:
Size Exclusion Chromatography (SEC)
Dynamic Light Scattering
Light Scattering
Industry:
Biologics

Speakers

  • John Stenson - Product Manager Nanomaterials

More information

Who should attend?

  • Scientists working in pharmaceutical and biologic analytical development, formulation and stability assessment.
  • Those working with viral vector development, gene therapies and associated sample types.